Elevated Levels of SOX10 in Serum from Vitiligo and Melanoma Patients, Analyzed by Proximity Ligation Assay

• Andries Blokzijl ,
• Lei E. Chen ,
• Sigrun M. Gustafsdottir,
• Jimmy Vuu,
• Gustav Ullenhag,
• Olle Kämpe,
• Ulf Landegren,
• Masood Kamali-Moghaddam,
• Håkan Hedstrand

Published: April 25, 2016

http://dx.doi.org/10.1371/journal.pone.0154214

---

Curr Oncol Rep. 2016 Jun;18(6):34. doi: 10.1007/s11912-016-0524-y.

Cell Cycle Regulation and Melanoma.

Xu W¹, McArthur G^2,3,4,5,6,7.

---

Cell Cycle. 2016 Apr 22:0. [Epub ahead of print]

The metabolic microenvironment of melanomas: prognostic value of MCT1 and MCT4.

Pinheiro C^1,2, Miranda-Gonçalves V^3,4, Longatto-Filho A^2,3,4,5, Vicente AL², Berardinelli GN², Scapulatempo C⁶, Costa RF¹, Viana CR⁶, Reis RM^2,3,4, Baltazar F^3,4, Vazquez VL^2,7.

---

Sensing of the Melanoma Biomarker TROY Using Silicon Nanowire Field-Effect Transistors

Carsten Maedler^†, Daniel Kim^†, Remco A. Spanjaard^‡, Mi Hong^†, Shyamsunder Erramilli^†¶, and Pritiraj Mohanty^*†

^† Department of Physics, Boston University, 590 Commonwealth Avenue, Boston, Massachusetts 02215, United States

^‡ Femto Diagnostics, 53 Bay State Road, Boston, Massachusetts 02215, United States

^¶ Department of Biomedical Engineering and Photonics Center, Boston University, 8 St. Mary’s Street, Boston, Massachusetts 02215, United States

ACS Sens., Article ASAP

DOI: 10.1021/acssensors.6b00017

Publication Date (Web): April 21, 2016

Copyright © 2016 American Chemical Society

---

“Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme"

Anna Laurenzana, Alessio Biagioni, Silvia D’Alessio, Francesca Bianchini, Anastasia Chillà, Francesca Margheri, Cristina Luciani, Benedetta Mazzanti, Nicola Pimpinelli, Eugenio Torre, Silvio Danese, Lido Calorini, Mario Del Rosso, Gabriella Fibbi,

Oncotarget, 5 (2014)

---

Hugo, W. et al. Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma. Cell 165, 35–44 (2016)

---

Dermatology
(DOI:10.1159/000444050)

ING4 Inhibits Proliferation and Induces Apoptosis in Human Melanoma A375 Cells via the Fas/Caspase-8 Apoptosis Pathway

Ma Y.^a · Cheng X.^a · Wang F.^a · Pan J.^a · Liu J.^a · Chen H.^c · Wang Y.^b · Cai L.^a

^aDepartment of Dermatology, First Affiliated Hospital of Harbin Medical University, and^bDepartment of Dermatology, Second Affiliated Hospital of Harbin Medical University, Harbin, and ^cDepartment of Dermatology, Chinese People’s Liberation Army 404st Hospital, Weihai, PR China

---

American Journal of Ophthalmology

Tumor volumes in choroidal melanoma: agreement between three-dimensional ultrasound and two mathematical models

• Josep M. Caminal,
• Karol Mejía,
• Luis Arias,
• Cristina Masuet-Aumatell,
• Jon Larrucea-Maseda,
• Ignasi Modolell,
• Daniel Lorenzo,
• Jaume Català,
• Marc Rubio,
• Estefanía Cobos,
• Pere Garcia-Bru,
• Ignacio Flores,
• Alejandro Filloy,
• Jordi Arruga

DOI: http://dx.doi.org/10.1016/j.ajo.2016.03.046

---

JAAD Case Rep. 2015 Nov 24;1(6):S26-8. doi: 10.1016/j.jdcr.2015.09.013. eCollection 2015.

Treatment options for metastatic melanoma in solid organ transplant recipients.

Shin TM¹, Gangadhar T², Miller CJ¹.

---

Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq

1. Itay Tirosh¹,*, 
2. Benjamin Izar¹,²,³,*,†,‡, 
3. Sanjay M. Prakadan¹,⁴,⁵,⁶, 
4. Marc H. Wadsworth II¹,⁴,⁵,⁶, 
5. Daniel Treacy¹, 
6. John J. Trombetta¹, 
7. Asaf Rotem¹,²,³, 
8. Christopher Rodman¹, 
9. Christine Lian⁷, 
10. George Murphy⁷,
11. Mohammad Fallahi-Sichani⁸, 
12. Ken Dutton-Regester¹,²,⁹, 
13. Jia-Ren Lin¹⁰, 
14. Ofir Cohen¹, 
15. Parin Shah², 
16. Diana Lu¹, 
17. Alex S. Genshaft¹,⁴,⁵,⁶, 
18. Travis K. Hughes¹,⁴,⁶,¹¹, 
19. Carly G. K. Ziegler¹,⁴,⁶,¹¹, 
20. Samuel W. Kazer¹,⁴,⁵,⁶, 
21. Aleth Gaillard¹,⁴,⁵,⁶, 
22. Kellie E. Kolb¹,⁴,⁵,⁶, 
23. Alexandra-Chloé Villani¹, 
24. Cory M. Johannessen¹, 
25. Aleksandr Y. Andreev¹, 
26. Eliezer M. Van Allen¹,²,³, 
27. Monica Bertagnolli¹²,¹³, 
28. Peter K. Sorger⁸,¹⁰,¹⁴, 
29. Ryan J. Sullivan¹⁵,
30. Keith T. Flaherty¹⁵, 
31. Dennie T. Frederick¹⁵, 
32. Judit Jané-Valbuena¹, 
33. Charles H. Yoon¹²,¹³,†, 
34. Orit Rozenblatt-Rosen¹,†, 
35. Alex K. Shalek¹,⁴,⁵,⁶,¹¹,¹⁶,†, 
36. Aviv Regev¹,¹⁷,¹⁸,†,‡, 
37. Levi A. Garraway¹,²,³,¹⁴,†,‡

Science  08 Apr 2016:
Vol. 352, Issue 6282, pp. 189-196
DOI: 10.1126/science.aad0501

 

---

SCS macrophages suppress melanoma by restricting tumor-derived vesicle–B cell interactions

1. Ferdinando Pucci¹,*, 
2. Christopher Garris¹,², 
3. Charles P. Lai³,†, 
4. Andita Newton¹, 
5. Christina Pfirschke¹,
6. Camilla Engblom¹,², 
7. David Alvarez⁴, 
8. Melissa Sprachman¹, 
9. Charles Evavold¹,², 
10. Angela Magnuson¹, 
11. Ulrich H. von Andrian⁴, 
12. Katharina Glatz⁵, 
13. Xandra O. Breakefield³, 
14. Thorsten R. Mempel⁶, 
15. Ralph Weissleder¹,
16. Mikael J. Pittet¹,‡

Science  08 Apr 2016:
Vol. 352, Issue 6282, pp. 242-246
DOI: 10.1126/science.aaf1328

---

© 2016 by American Society of Clinical Oncology

Vitamin D and Melanoma: What Do We Tell Our Patients?

1. Vernon K. Sondak,
2. Bryan McIver and
3. Peter A. Kanetsky

Published online before print April 4, 2016, doi:10.1200/JCO.2016.66.5240JCO April 4, 2016 JCO665240

---

Oncogene advance online publication 4 April 2016; doi: 10.1038/onc.2016.67

CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation

P Zhang^1,2,6, S Feng^1,6, G Liu^3,6, H Wang^3,6, A Fu¹, H Zhu¹, Q Ren¹, B Wang⁴, X Xu¹, H Bai¹ and C Dong⁵

---

Journal of the American College of Surgeons

Status of the Regional Nodal Basin Remains Highly Prognostic in Melanoma Patients with In-Transit Disease

Presented at the Western Surgical Association 123rd Scientific Session, Napa Valley, CA, November 2015.

• Alexandra B. Gonzalez, BS,
• James W. Jakub, MD, FACS,
• William S. Harmsen, MS,
• Vera J. Suman, PhD,
• Svetomir N. Markovic, MD, PhD

DOI: http://dx.doi.org/10.1016/j.jamcollsurg.2016.03.025

---

---

Melanoma addiction to the long non-coding RNASAMMSON

• Eleonora Leucci,
• Roberto Vendramin,
• Marco Spinazzi,
• Patrick Laurette,
• Mark Fiers,
• Jasper Wouters,
• Enrico Radaelli,
• Sven Eyckerman,
• Carina Leonelli,
• Katrien Vanderheyden,
• Aljosja Rogiers,
• Els Hermans,
• Pieter Baatsen,
• Stein Aerts,
• Frederic Amant,
• Stefan Van Aelst,
• Joost van den Oord,
• Bart de Strooper,
• Irwin Davidson,
• Denis L. J. Lafontaine,
• Kris Gevaert,
• Jo Vandesompele,
• Pieter Mestdagh
• & Jean-Christophe Marine

Nature 531, 518–522 (24 March 2016) doi:10.1038/nature17161

Received 21 December 2015

Accepted 21 January 2016

Published online 23 March 2016

---

Sci Rep. 2016 Apr 28;6:25182. doi: 10.1038/srep25182.

Consequences of point mutations in melanoma-associated antigen 4 (MAGE-A4) protein: Insights from structural and biophysical studies.

Hagiwara Y¹, Sieverling L¹, Hanif F¹, Anton J¹, Dickinson ER², Bui TT³, Andreeva A⁴, Barran PE², Cota E⁵, Nikolova PV¹.

_________________________________________________

Cancer Med. 2016 Apr 26. doi: 10.1002/cam4.717. [Epub ahead of print]

Real-world treatment practice in patients with advanced melanoma in the era before ipilimumab: results from the IMAGE study.

Middleton MR¹, Dalle S², Claveau J³, Mut P⁴, Hallmeyer S⁵, Plantin P⁶, Highley M⁷, Kotapati S⁸, Le TK⁸, Brokaw J⁸, Abernethy AP⁹.